Role	O
of	O
runt	O
-	O
related	O
transcription	O
factor	O
3	O
(	O
RUNX3	O
)	O
in	O
transcription	O
regulation	O
of	O
natural	O
cytotoxicity	O
receptor	O
1	O
(	O
NCR1	O
/	O
NKp46	O
)	O
,	O
an	O
activating	O
natural	O
killer	O
(	O
NK	O
)	O
cell	O
receptor	O
.	O


Natural	O
cytotoxicity	O
receptor	O
1	O
(	O
NCR1	O
)	O
,	O
also	O
known	O
as	O
NKp46	O
,	O
is	O
a	O
natural	O
killer	O
(	O
NK	O
)	O
lymphocyte	O
-	O
activating	O
receptor	O
.	O


It	O
is	O
involved	O
in	O
major	O
aspects	O
of	O
NK	O
immune	O
function	O
and	O
shows	O
a	O
high	O
degree	O
of	O
lineage	O
specificity	O
in	O
blood	O
and	O
bone	O
marrow	O
.	O


The	O
nature	O
of	O
its	O
NK	O
-	O
restricted	O
expression	O
is	O
not	O
well	O
understood	O
.	O


In	O
this	O
study	O
,	O
we	O
confirm	O
that	O
human	O
NCR1	O
NK	O
-	O
specific	O
expression	O
is	O
achieved	O
at	O
the	O
mRNA	O
level	O
.	O


We	O
found	O
two	O
key	O
cis	O
-	O
regulatory	O
elements	O
in	O
the	O
immediate	O
vicinity	O
upstream	O
of	O
the	O
gene	O
.	O


One	O
element	O
acts	O
as	O
an	O
essential	O
promoter	O
,	O
whereas	O
the	O
other	O
acts	O
as	O
a	O
tissue	O
-	O
dependent	O
enhancer	O
/	O
repressor	O
.	O


This	O
latter	O
regulatory	O
element	O
contains	O
a	O
runt	O
related	O
-	O
transcription	O
factor	O
(	O
RUNX	O
)	O
recognition	O
motif	O
that	O
preferentially	O
binds	O
RUNX3	O
.	O


Interfering	O
with	O
RUNX	O
proteins	O
using	O
a	O
dominant	O
negative	O
form	O
results	O
in	O
decreased	O
Ncr1	O
expression	O
.	O


RUNX3	O
overexpression	O
had	O
the	O
opposite	O
effect	O
.	O


These	O
findings	O
shed	O
light	O
on	O
the	O
role	O
of	O
RUNX3	O
in	O
the	O
control	O
of	O
an	O
important	O
NK	O
-	O
activating	O
receptor	O
.	O
